FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Seattle Daily Journal of Commerce15h
Life Science Washington
Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...
SchaeffersResearch.com7d
Biotech Stock Rises After FDA Approves Non-Opioid Painkiller
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock is up 6% at $465.02 at last glance, after the U.S. Food and Drug ...
Washington Times8d
Historic FDA approval marks first nonopioid breakthrough since Clinton era
Sold by Vertex Pharmaceuticals in 50-milligram tablets as Journavx, suzetrigine is the first nonopioid painkiller to target pain-signaling pathways in the peripheral nervous system before those ...
The Patriot Ledger7d
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
Vertex Pharmaceuticals is a biotech company based in Boston, Massachusetts. Its headquarters are in Boston's Seaport neighborhood, and it also has a research site in Cambridge's Kendall Square.
Times News3d
FDA approves painkiller designed to eliminate risk of addiction
Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.
Newsday7d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON — Federal officials on Thursday ... The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
turnto108d
FDA approves painkiller designed to eliminate risks of addiction associated with opioids
WASHINGTON (AP ... The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...